BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

10630	Companies
225898	Keywords
154432	Articles
119543	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

PRESS RELEASE

published on 08/09/2025 at 01:00, 10 months 15 days ago

BioNxt Solutions Announces Closing of Final Tranche of Oversubscribed Convertible Debenture Unit Private Placement
BioNxt Solutions Inc. closes final tranche of non-brokered private placement, raising $241,200 for convertible debentures and issuing Warrants. Funds intended for product development and IP filings

Private Placement Warrants Convertible Debentures BioNxt Solutions Inc. Product Development
BRIEF

published on 08/05/2025 at 09:10, 10 months 19 days ago

BioNxt Solutions renforce la protection des brevets pour le traitement de la sclérose en plaques

Sclérose En Plaques Technologie D'administration De Médicaments Solutions BioNxt Cladribine Sublinguale Protection Par Brevet
BRIEF

published on 08/05/2025 at 09:10, 10 months 19 days ago

BioNxt Solutions Advances Patent Protection for MS Treatment

Multiple Sclerosis Drug Delivery Technology Patent Protection BioNxt Solutions Sublingual Cladribine
PRESS RELEASE

published on 08/05/2025 at 09:05, 10 months 19 days ago

BioNxt Solutions Reports Pending Patent Grants in Europe and Eurasia, Strengthening IP Protection for Proprietary Sublingual Cladribine-Based MS Treatment
BioNxt Solutions Inc. makes significant progress in global patent portfolio with EPO and EAPO confirming acceptance of core claims for sublingual Cladribine thin-film formulation. Focus on innovation in MS treatment

BioNxt Solutions Inc. Patent Portfolio Cladribine EPO EAPO
BRIEF

published on 07/26/2025 at 00:05, 10 months 29 days ago

BioNxt Solutions clôture la première tranche de son placement d'obligations

Obligations Convertibles Placement Privé Développement De Produits Mandats Solutions BioNxt
BRIEF

published on 07/26/2025 at 00:05, 10 months 29 days ago

BioNxt Solutions Closes First Tranche of Debenture Placement

Private Placement Warrants Convertible Debentures Product Development BioNxt Solutions
PRESS RELEASE

published on 07/26/2025 at 00:00, 10 months 29 days ago

BioNxt Solutions Announces Closing of First Tranche of Convertible Debenture Unit Private Placement
BioNxt Solutions Inc. closes first tranche of non-brokered private placement, raising $1,009,200 for drug delivery tech and IP development. Securities subject to statutory hold until Nov 26, 2025

Private Placement Convertible Debentures BioNxt Solutions Inc. Intellectual Property Drug Delivery Technologies
BRIEF

published on 07/23/2025 at 09:10, 11 months 1 day ago

BioNxt Advances Cladribine Thin-Film Development

Multiple Sclerosis Cladribine Drug Delivery BioNxt Solutions Sublingual Thin-Film
BRIEF

published on 07/23/2025 at 09:10, 11 months 1 day ago

BioNxt fait progresser le développement de couches minces de cladribine

Sclérose En Plaques Cladribine Solutions BioNxt Administration De Médicaments Film Mince Sublingual
PRESS RELEASE

published on 07/23/2025 at 09:05, 11 months 1 day ago

BioNxt Delivers Positive Results in Patented Cladribine Sublingual Thin-Film Program and Completes Successful Formulation
BioNxt Solutions Inc. announces successful development of sublingual thin-film prototype for cladribine-based drug delivery in multiple sclerosis treatment, strengthening clinical development path

BioNxt Solutions Inc. Cladribine Drug Delivery Multiple Sclerosis Treatment Thin-film Prototype

Accesswire

Published on 06/24/2026 at 14:45, 1 hour 53 minutes ago

Amdocs Selected by Three Scandinavia to Support Customer Engagement Transformation Across Nordic Markets
Published on 06/24/2026 at 14:00, 2 hours 38 minutes ago

GameSquare and U.S. Army Partner for Soldier Showdown 8, Presented by USAA
Published on 06/24/2026 at 14:00, 2 hours 38 minutes ago

Adcore Announces Voting Results from Annual Shareholders Meeting
Published on 06/24/2026 at 13:05, 3 hours 33 minutes ago

Faraday Copper Reports Drill Results Including Near-Surface Copper Mineralization in the American Eagle Area
Published on 06/24/2026 at 13:00, 3 hours 38 minutes ago

Aston Bay Provides Update on the Storm Copper Project - Advancing Towards Development

View all ACCESSWIRE

EQS Group

Published on 06/24/2026 at 16:05, 32 minutes ago

Tencent Backs Next-Gen Decarbonization Innovators with Catalytic Funding Through CarbonX 2.0 and Advances Progress Towards Climate Goals
Published on 06/24/2026 at 16:05, 32 minutes ago

Sunwoda Energy Launches SunESS H Series and Deepens European Partnerships
Published on 06/24/2026 at 16:00, 38 minutes ago

Dynamics Group accueille Mark Seall comme nouvel associé - Cette nomination vient renforcer les compétences technologiques du groupe de conseil dans un environnement marqué par l’IA
Published on 06/24/2026 at 15:49, 48 minutes ago

Edison issues report on SDCL Efficiency Income Trust (SEIT)
Published on 06/24/2026 at 15:44, 54 minutes ago

Eckert & Ziegler SE Annual General Meeting Approves Significantly Higher Dividend

Les Echos

Published on 06/24/2026 at 16:21, 16 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of May 31, 2026
Published on 06/24/2026 at 16:21, 16 minutes ago

Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 mai 2026
Published on 06/24/2026 at 16:17, 20 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of April 30, 2026
Published on 06/24/2026 at 16:17, 20 minutes ago

Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 30 avril 2026
Published on 06/24/2026 at 09:30, 7 hours 8 minutes ago

CP HOPENING - Le 1er Baromètre “Libéralités - Grande Transmission”

View all LES ECHOS COMFI WIRE